ELMD vs TCMD
ELMD: Electromed provides innovative airway clearance therapy through its SmartVest systems to help patients with chronic pulmonary conditions breathe easier. TCMD: Tactile Medical develops at-home therapeutic medical devices that improve quality of life and reduce healthcare costs for patients with chronic vascular and respiratory conditions.
Side-by-side fundamentals
| Metric | ELMD | TCMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $39.52 | $27.62 | |
| Market cap as of 2026-07-23 | $336M | $622M | |
| P/E as of 2026-07-23 | 33.21 | 30.65 | TCMD lower |
| PEG as of 2026-07-23 | 0.76 | 0.95 | ELMD lower |
| Net margin as of 2026-07-23 | +14.1% | +5.9% | ELMD higher |
| Gross margin as of 2026-07-23 | +78.4% | +51.3% | ELMD higher |
| Operating margin as of 2026-07-23 | +18.3% | +9.4% | ELMD higher |
| ROE as of 2026-07-23 | +22.1% | +9.7% | ELMD higher |
| ROA as of 2026-07-23 | +18.2% | +7.5% | ELMD higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-07-23 | +16.8% | +17.2% | TCMD higher |
| Revenue CAGR (3y) SEC XBRL | +15.4% | +10.1% | ELMD higher |
| Beta as of 2026-07-23 | 0.51 | 0.82 | |
| 1-year return as of 2026-07-22 close | +123.6% | +176.5% | TCMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.